Inferior versus medial approach in laparoscopic and robotic surgery with complete mesocolic excision for right-sided colon cancer: propensity score-matched analysis - Takeaways - MDSpire

Inferior versus medial approach in laparoscopic and robotic surgery with complete mesocolic excision for right-sided colon cancer: propensity score-matched analysis

  • By

  • S. Izukawa

  • M. Numata

  • T. Harada

  • Y. Atsumi

  • K. Kazama

  • S. Sawazaki

  • T. Godai

  • H. Mushiake

  • A. Higuchi

  • H. Tamagawa

  • Y. Suwa

  • J. Watanabe

  • T. Sato

  • A. Saito

  • July 30, 2025

  • 0 min

Share

  • 1

    Complete mesocolic excision (CME) and central vascular ligation (CVL) are standard techniques for improving outcomes in right-sided colon cancer surgery.

  • 2

    The perioperative mortality rate for right hemicolectomy is 1.4%, highlighting the complexity and risks associated with this procedure.

  • 3

    The medial approach (MA) and inferior approach (IA) are two primary techniques for right-sided colon cancer, differing in bowel mobilization and dissection timing.

  • 4

    A multicenter study utilized propensity score matching to compare the perioperative performance of MA and IA in right-sided colon cancer surgeries.

  • 5

    Surgeon experience varied among the 83 participating surgeons, classified into three groups based on years of surgical practice.

Original Source(s)

Inferior versus medial approach in laparoscopic and robotic surgery with complete mesocolic excision for right-sided colon cancer: propensity score-matched analysis

  • by S. Izukawa, M. Numata, T. Harada, Y. Atsumi, K. Kazama, S. Sawazaki, T. Godai, H. Mushiake, A. Higuchi, H. Tamagawa, Y. Suwa, J. Watanabe, T. Sato, A. Saito

  • July 30, 2025

Related Content

Dye-free versus dye-containing submucosal injection solutions in ESD for colorectal LST: a multi-center retrospective study on efficacy and safety

Colorectal Cancer Treatment During Pregnancy

Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.

Error in Abstract

  • May 15, 2026